Bentham Science Logo

Track Your Manuscript:


Current Drug Safety

Volume 15, 3 Issues, 2020
ISSN: 2212-3911 (Online)
ISSN: 1574-8863 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Drug Safety, Volume 11 - Number 1









Biologic Therapy in Inflammatory Eye Conditions (Ophtalmology): Safety Profile

, 11(1): 47 - 54

Piergiorgio Neri, Ilir Arapi, Michele Nicolai, Vittorio Pirani, Andrea Saitta, Michele M. Luchetti, Alfonso Giovannini and Cesare Mariotti


DOI: 10.2174/1574886310666151014114925





Adverse Effects Cause Varenicline Discontinuation: A Meta-Analysis

, 11(1): 78 - 85

Aaron D. Drovandi, Carla C. Chen and Beverley D. Glass


DOI: 10.2174/1574886311207040282



Drug-Induced QTc Interval Prolongation: A Multicenter Study to Detect Drugs and Clinical Factors Involved in Every Day Practice

, 11(1): 86 - 98

Guillermo A. Keller, Paulino A. Alvarez, Marcelo L. Ponte, Waldo H. Belloso, Claudia Bagnes, Cecilia Sparanochia, Claudio D. Gonzalez, M. Cecilia Villa Etchegoyen, Roberto A. Diez and Guillermo Di Girolamo


DOI: 10.2174/1574886311207040262




Recognizing Severe Adverse Drug Reactions: Two Case Reports After Switching Therapies to the Same Generic Company

, 11(1): 104 - 108

Luca Gallelli, Giuseppe Gallelli, Giuseppe Codamo, Angela Argentieri, Andzelika Michniewicz, Antonio Siniscalchi, Roberta Stefanelli, Erika Cione, Maria C. Caroleo, Paola Longo and Giovambattista De Sarro


DOI: 10.2174/1574886311207040309




Editor-in-Chief

Seetal Dodd
University of Melbourne
Geelong, Melbourne
(Australia)
Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Drug Safety Journal was launched in 2006. Dr. Seetal Dodd serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.15

Advertisement

Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog